Dulaglutide vs Durvalumab

Dulaglutide vs Durvalumab: Overview

This comparison examines the pharmacological differences between Dulaglutide and Durvalumab.

Mechanism of Action

Dulaglutide: GLP-1 receptor agonist fused to Fc fragment; enhances glucose-dependent insulin secretion.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Dulaglutide — 5 days; Durvalumab — 17 days.

Chemical Properties

Type: Dulaglutide — Protein; Durvalumab — Antibody.